The many meanings of Alzheimer's disease and why they matter for policy, research, and care.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  GeroScience

• Publication date

  2026-02-09

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s11357-026-02131-zPMID 41656391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup

  2025cited by this paper
• New landscape of the diagnosis of Alzheimer's disease.

  2025cited by this paper
• The landscape of autosomal-dominant Alzheimer’s disease: global distribution and age of onset

  2025cited by this paper
• The controversy around anti-amyloid antibodies for treating Alzheimer’s disease

  2024cited by this paper
• Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation.

  2024cited by this paper
• Dementia diagnosis in the anti-amyloid era.

  2024cited by this paper
• Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications

  2024cited by this paper
• Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

  2024cited by this paper
• Multifaceted roles of APOE in Alzheimer disease

  2024cited by this paper
• Aducanumab for the treatment of Alzheimer's disease: a systematic review

  2023cited by this paper
• A New Framework for Dementia Nomenclature.

  2023cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2022cited by this paper
• Heterogeneity in Alzheimer’s Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials

  2022cited by this paper
• Neuropathology of the Common Forms of Dementia.

  2022cited by this paper
• Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility.

  2021cited by this paper
• Alzheimer's disease associated with Down syndrome: a genetic form of dementia.

  2021cited by this paper
• The neuropathological diagnosis of Alzheimer’s disease

  2019cited by this paper
• The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management.

  2019cited by this paper
• The Challenge of Defining Alzheimer Disease Based on Biomarkers in the Absence of Symptoms.

  2019cited by this paper
• A brief history of “Alzheimer disease”

  2019cited by this paper
• Impact of multiple pathologies on the threshold for clinically overt dementia

  2017cited by this paper
• The amyloid hypothesis of Alzheimer's disease at 25 years

  2016cited by this paper
• The genetics of Alzheimer disease: back to the future.

  2010cited by this paper
• Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

  2009cited by this paper
• Mild Cognitive Impairment.

  2004cited by this paper

• No citing papers are available for this paper.